Gland Pharma Share Price: Gland Pharma shares rose 12% despite a 15.7% YoY profit decline in Q2. Kotak upgraded the stock to ‘Reduce’ with a revised target price of Rs 1,625, citing improved core business performance.
Just Dial reported a 43% YoY rise in Q3FY25 net profit to ₹131.31 crore, with revenue up 8.4% to ₹287.33 crore. Sequentially, profit declined 15%.
In December, 34 mutual fund NFOs raised Rs 13,852 crore, with 33 open-ended and one close-ended fund. Sectoral and thematic funds led with Rs 11,337
Advertiser Disclosure
Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.
Disclaimer
It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information
Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003